News

Ajanta Pharma introduces memantine hydrochloride tablets in US market

Ajanta-Pharma

Ajanta Pharma Limited, announced the launch of memantine hydrochloride tablets in the US market through its wholly owned subsidiary Ajanta Pharma USA Inc. Memantine hydrochloride is an anti-dementia drug and is a bioequivalent generic version of Namenda.Ajanta-Pharma

The company has launched it in 2 strengths 5mg and 10mg tablets to address different levels of treatment.

Memantine hydrochloride tablets is part of an ever-growing portfolio of products that Ajanta has developed for the US market. To date, the United States Food & Drug Administration (FDA) has granted Ajanta Pharma 10 final approvals and 2 tentative approvals for its Abbreviated New Drug Application (ANDA). Additional 14 ANDAs are pending approval from the FDA.

Don't be shellfish...Share on Facebook0Share on Google+0Share on LinkedIn0Share on StumbleUpon0Pin on Pinterest0Tweet about this on Twitter0
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Most Popular

To Top